Compstatin control peptide
Cat. No. 3796
Biological ActivityControl peptide for Compstatin (Cat. No. 2585), a complement inhibitor.
(Modifications: Thr-13 = C-terminal amide)
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Mollnes et al (2002) Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100 1869. PMID: 12176911.
Fiane et al (1999) Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation 6 52. PMID: 10355733.
Sahu et al (1996) Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J.Immunol. 157 884. PMID: 8752942.
If you know of a relevant reference for Compstatin control peptide please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Compstatin control peptide from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Compstatin control peptide, supplier, C3-binding, protein, inhibits, inhibitors, complement, activation, Convertase, control, peptide, Tocris Bioscience, Complement products